23 results
8-K
EX-2.1
SPRY
ARS Pharmaceuticals Inc
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
-19 pandemic, to the extent reasonably necessary, (A) to protect the health and safety of Parent’s employees, (B) to respond to third party supply … ) as required by applicable Law, (iv) in connection with the COVID-19 pandemic, to the extent reasonably necessary, (A) to protect the health and safety
DEFM14A
bzp7a7orr5d abcfrd09
6 Oct 22
Proxy related to merger
4:16pm
PRER14A
igikkcfuoac8
16 Sep 22
Preliminary revised proxy
4:56pm
PREM14A
8licv3fni br1q41u
11 Aug 22
Preliminary proxy related to merger
5:22pm
DEFA14A
as0dp lxd3murr
21 Jul 22
Additional proxy soliciting materials
5:05pm
8-K
EX-2.1
ze3f 5aypov6c
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
10-Q
vlks8
13 May 21
Quarterly report
4:21pm
10-K
68i0t5orfq3uxxfz
29 Mar 21
Annual report
4:13pm
424B4
y3uk4cpy
4 Dec 20
Prospectus supplement with pricing info
4:04pm